Subscribe
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma

Videos

  • Webinars
  • 2018 AONN+ Midyear Conference
  • 2018 ASCO Insights
  • AVBCC
  • AVBCC 2016
  • Payer-Provider
  • Personalized Medicine
  • Pricing
  • SABCS 2017
  • EHA 2016
  • WCLC 2016 - Lung Cancer
  • View All Videos ›
Patients and Treatment Discussions
Patients and Treatment Discussions
FEATURING:
Gary Palmer, MD
November 24, 2014
Personalized Medicine
Watch Video
Multidisciplinary Care, a paradigm shift
Multidisciplinary Care, a paradigm shift
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Multidisciplinary Care
Watch Video
Benefits of Multidisciplinary Care
Benefits of Multidisciplinary Care
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Multidisciplinary Care
Watch Video
Cancer Care Pathways
Cancer Care Pathways
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Pathways
Watch Video
The Value of Value-Based Cancer Care
The Value of Value-Based Cancer Care
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Testimonials
Watch Video
Community Oncology Practices
Community Oncology Practices
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Community Oncology
Watch Video
Defining ACOs
Defining ACOs
FEATURING:
Mark J. Krasna, MD
May 2, 2014
Accountable Care Organization
Watch Video

Page 14 of 14

  • 11
  • 12
  • 13
  • 14

Top Trending Articles

1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma
Subscribe

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
  • About
  • About VBCC
  • Mission Statement
  • Advertising
  • Contact
  • Contribute
  • Submit a Manuscript
  • Editorial / Publishing Policies
  • Author Guidelines
  • Publications
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Cholangiocarcinoma News
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.